At a glance
ClinicalIndex Comparison RecordN/ACompleted· 455 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ANEMIA MANAGEMENT IN CHRONIC KIDNEY DISEASE NOT ON DIALYSIS PATIENTS AFTER THE ERBP WORKING GROUP RECOMMENDATIONS
In Brief
An observational study for ANEMIA. Completed, enrolled 455 participants across 29 sites.
Detailed Summary
The purpose of this study is to evaluate the impact of the last recommendations of the European Anemia Working Group ERBP in the anemia management in the achievement of the therapeutic goal of Hb 11-12 g/dL.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsANEMIA
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2011
Primary CompletionJun 2012
First PostedJul 2013
TodayJul 2026
First PostedJul 19, 2013
Enrollment StartOct 1, 2011
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 13.0 years ago